ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Chronic Myelomonocytic Leukemia

Acute Myeloid Leukemia (AML) trials near Portland, OR, USA:

Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia (SIERRA)

allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...

Active, not recruiting
AML
Acute Myelogenous Leukemia
Drug: Iomab-B
Drug: Conventional Care

Phase 3

Actinium Pharmaceuticals
Actinium Pharmaceuticals

Portland, Oregon, United States and 23 other locations

People with acute myeloid leukemia (AML) are usually treated with chemotherapy. Some people with AML hav...

Enrolling
Acute Myeloid Leukemia (AML)
FLT3-mutated Acute Myeloid Leukemia
Drug: Azacitidine
Drug: Venetoclax

Phase 1, Phase 2

Astellas
Astellas

Portland, Oregon, United States and 19 other locations

Locations recently updated

\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Fludarabine

Phase 3

PedAL BCU, LLC

Portland, Oregon, United States and 85 other locations

This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Portland, Oregon, United States and 160 other locations

standard induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. Pemigatinib selectively inhibits ...

Enrolling
Acute Myeloid Leukemia
Procedure: Bone Marrow Aspirate
Drug: Cytarabine

Phase 1

OHSU Knight Cancer Institute
OHSU Knight Cancer Institute

Portland, Oregon, United States and 1 other location

to placebo and VEN+AZA alone for the treatment of participants with Acute Myeloid Leukemia (AML) with a mutation ...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Portland, Oregon, United States and 169 other locations

GDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (A...

Active, not recruiting
Leukemia
Drug: GDX012
Drug: Chemotherapy Agents

Phase 1, Phase 2

Takeda
Takeda

Portland, Oregon, United States and 13 other locations

in subjects with relapsed/refractory B cell malignancies or AML after failure of standard therapies or voruciclib in combination with veneto...

Enrolling
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Drug: voruciclib and venetoclax
Drug: voruciclib monotherapy

Phase 1

MEI Pharma

Portland, Oregon, United States and 11 other locations

participants with AML.The duration of this multi-phase study is approximately 7 years....

Enrolling
Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Drug: Venetoclax
Drug: ASTX030 (cedazuridine + azacitidine)

Phase 2, Phase 3

Taiho Pharma
Taiho Pharma

Portland, Oregon, United States and 71 other locations

This phase I trial studies the side effects of donor natural killer (NK) cell therapy in treating patients with acute myeloid leukemia...

Active, not recruiting
Refractory Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
Drug: Cytarabine Hydrochloride
Drug: Fludarabine

Phase 1

Sumithira Vasu

Portland, Oregon, United States and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems